Recent child pharmacoepidemiological findings

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 1, 2005, Pages 5-9

  Zito, J M ^a   Safer, D J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; DRUG USE; DRUG UTILIZATION; EDITORIAL; ETHNIC DIFFERENCE; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION SYSTEM; INSURANCE; MEDICAID; MENTAL DISEASE; MOOD DISORDER; PEDIATRICS; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION; PREVALENCE; RACE DIFFERENCE;

CHILD; CHILD, PRESCHOOL; HUMANS; MENTAL DISORDERS; PHARMACOEPIDEMIOLOGY; PSYCHOTROPIC DRUGS;

EID: 14944359641     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.5     Document Type: Editorial

References (14)

1. Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA: New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med 158:753-759, 2004.
2. Cox ER, Motheral BR, Henderson RR, Mager D: Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: Results from a commercially insured US sample. Pediatrics 111:237-243, 2003.
3. dosReis S, Zito JM, Safer DJ, Soeken K, Mitchell J, Ellwood L: Parental perceptions and satisfaction with stimulant medication for attention deficit hyperactivity disorder. J Dev Behav Pediatric 324: 1-8, 2003.
4. Kaplan SL, Simms RM, Busner J: Prescribing practices of outpatient child psychiatrists. J Am Acad Child Adolesc Psychiatry 33:35-44, 1994.
5. Martin A, Leslie D: Trends in psychotropic medication costs for children and adolescents, 1997-2000. Arch Pediatr Adolesc Med 157:997-1004, 2003.
6. Martin A, VanHoof T, Stubbe D, Sherwin T, Scahill L: Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services 54:72-77, 2003.
7. Olfson M, Gameroff MJ, Marcus SC, Jensen PS: National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 160:1071-1077, 2003.
8. Rushton JL, Whitmire JT: Pediatric stimulant and SSRI prescription trends: 1992-1998. Arch Pediatr Adolesc Med 155:560-565, 2001.
9. Safer DJ: Changing patterns of psychotropic medication prescribed by child psychiatrists in the 1990s. J Child Adolesc Psychopharmacol 7: 267-273, 1997.
10. Safer DJ, Zito JM: Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of ADHD. In: Ritalin: Theory and Practice, 2nd ed. Edited by Greenhill LL, Osman BB. Larchmont (New York): Mary Ann Liebert, Inc., 2000, pp. 7-26.
11. Shatin D, Drinkard CR: Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambulatory Pediatrics 2:111-119, 2002.
12. Zarin DA, Suarez AP, Pincus HA, Kupersanin BA, Zito JM: Clinical and treatment characteristics of children with attention deficit/hyperactivity disorder in psychiatric practice. J Am Acad Child Adolesc Psychiatry 37:1262-1270, 1998.
13. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: A ten-year perspective. Arch Pediatr Adolesc Med 157:17-25, 2003.
14. Zito JM, Safer DJ, dosReis S, Gardner JF, Soeken K, Boles M, Lynch FL: Rising prevalence of anti-depressant treatments for U.S. children and adolescents. Pediatrics 109:721-727, 2002.